Last updated on August 2008

Juvenile Idiopathic Arthritis (JIA) - Minors

Brief description of study

Juvenile Idiopathic Arthritis (JIA) - Minors

Detailed Study Description

Parents with children with Juvenile Idiopathic Arthritis (JIA) are asked to participate in a research study being conducted by Schneider Children's Hospital.

Patient Inclusion Criteria
Your child may be eligible to participate in this study if your child:

  • Is 4 to 17 years old
  • Has been diagnosed with JIA
  • Is taking Humira® or MTX therapy

Patient Exclusion Criteria
Your child may not participate in this study if your child:

  • Cannot be treated with Humira®
  • Has been treated with any approved or experimental drug such as etanercept (Enbrel®), abatacept (Orencia®), infliximab (Remicade®) or rituximab (Rituxan®).
  • Has participated in another research study within the last 30 days.

Clinical Study Identifier: TX134394

Find a site near you

Start Over

Biomedical Research Alliance of New York

Schneider Children's Hospital<br /> 269-01 76th Avenue New Hyde Park, NY USA
  Connect »